SCHEMBL14744629

SCHEMBL14744629

Cc1cc2c(C(=O)Cl)cccc2o1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.38
CYP1A2 P05177 5/20 0.38
CYP1B1 Q16678 5/20 0.38
CYP2C19 P33261 1/20 0.37
ALDH1A1 P00352 2/20 0.36
GLA P06280 1/20 0.36
ALOX15 P16050 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CES2 O00748 1/20 0.36
GRM5 P41594 1/20 0.35
KDM4E B2RXH2 3/20 0.35
MAPT P10636 1/20 0.35
ACHE P22303 1/20 0.35
HPGD P15428 2/20 0.35
LMNA P02545 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CA12 O43570 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16160316 0.84 KDM4E (0.44) CYP1A1CYP1A2CYP1B1CYP2C19ALDH1A1
SCHEMBL496357 0.84 CA12 (0.44) CYP1A1CYP1A2CYP1B1ALDH1A1ALOX15
SCHEMBL1380868 0.83 ALDH1A1 (0.50) CYP1A1CYP1A2CYP1B1CYP2C19ALDH1A1
SCHEMBL1398744 0.80 NPC1 (0.48) ALDH1A1GLAKMT2AKDM4EMAPT
SCHEMBL6676335 0.78 TSHR (0.54) ALDH1A1GLAKDM4EMAPTHPGD
SCHEMBL8286028 0.72 AHR (0.42) CYP1A1CYP1A2CYP1B1ALDH1A1ACHE
SCHEMBL2268151 0.72 MAOA (0.44) CYP1A1CYP1A2CYP1B1CYP2C19ALOX15
SCHEMBL4586087 0.71 ALDH1A1 (0.53) ALDH1A1GLAALOX15KDM4EMAPT
SCHEMBL433952 0.71 CYP1A2 (0.46) CYP1A1CYP1A2CYP1B1ALDH1A1KDM4E
SCHEMBL4586057 0.70 ALOX5 (0.48) CYP2C19ALDH1A1GLAALOX15MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013033310-A1 MODULATORS OF REV-ERB KAMENECKA THEODORE MARK (US) 2013-03-07 WO disclosed